Article metrics
PDF
Other content recommended for you
- Threat of compulsory licences could increase access to essential medicines
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- Glossary on the World Trade Organisation and public health: part 2
- The COVID-19 vaccine patent: a right without rationale
- Patent wars: affordable medicines versus intellectual property rights
- A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review
- Overriding drug and medical technology patents for pandemic recovery: a legitimate move for high-income countries, too
- Intellectual property waiver for covid-19 vaccines will advance global health equity
- Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment
- Estimated costs of production and potential prices for the WHO Essential Medicines List